Quarterly report pursuant to Section 13 or 15(d)

Operating Leases - Additional Information (Details)

v3.23.2
Operating Leases - Additional Information (Details)
$ in Thousands
 3 Months Ended 6 Months Ended
Dec. 16, 2021
OfficeSuite
Nov. 17, 2021
USD ($)
Nov. 10, 2021
May 10, 2021
USD ($)
Jan. 27, 2021
OfficeSuite
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Lessee Lease Description [Line Items]                    
Operating lease right-of-use assets           $ 15,837   $ 15,837   $ 5,580
Operating lease liability           53,542   53,542    
Current portions of operating lease liability           2,914   2,914   4,045
Non-current portions of operating lease liability           $ 50,628   $ 50,628   $ 1,749
Remaining lease term on operating leases           111 months   111 months    
Weighted average incremental borrowing rate on operating lease           10.90%   10.90%    
Lease expense           $ 2,300 $ 1,600 $ 4,000 $ 3,300  
Variable lease payments           700 $ 400 1,100 $ 700  
Explora BioLabs, Inc                    
Lessee Lease Description [Line Items]                    
Operating lease right-of-use assets           200   200    
Operating lease liability           100   $ 100    
Lease Agreement                    
Lessee Lease Description [Line Items]                    
Lessee, operating lease, option to extend               The term of the lease is 44 months for the first office suite and 43 months for the second office suite with an option to extend the term for an additional two years on the same terms and conditions    
Number of office suites | OfficeSuite         2          
Operating lease right-of-use assets           15,800   $ 15,800    
Operating lease liability           53,400   $ 53,400    
First Office Suite                    
Lessee Lease Description [Line Items]                    
Operating lease commencement date     Nov. 10, 2021   Jul. 31, 2021          
Sublease expire date     Dec. 06, 2023              
Second Office Suite                    
Lessee Lease Description [Line Items]                    
Operating lease commencement date         Aug. 31, 2021          
Embedded Lease Agreement | Laboratory For Cell And Gene Medicine                    
Lessee Lease Description [Line Items]                    
Finance lease maturity date       Apr. 30, 2023            
Fixed lease payments       $ 5,600            
License Service Agreement and Master Services Agreement | Explora BioLabs, Inc                    
Lessee Lease Description [Line Items]                    
Finance lease maturity date   Nov. 30, 2023                
Fixed lease payments   $ 700                
Bayside Lease [Member]                    
Lessee Lease Description [Line Items]                    
Term of contract 120 months                  
Office And Laboratory Space | OfficeSuite 85,165                  
Lessee, operating lease, option to extend               The term of the lease is 120 months with the option to extend the term up to an additional ten years.    
Operating lease right-of-use assets           32,000   $ 32,000    
Operating lease liability           32,000   32,000    
Leasehold Improvements           27,200   27,200    
Leasehold Tenant Improvement Allowance               14,900    
Leasehold Improvements Liability Utilized and Recorded           14,700   14,700    
Restructuring Plan                    
Lessee Lease Description [Line Items]                    
Non-Cash Impairment Of Right-Of-Use Asset And Related Leasehold Improvement           $ 35,000   $ 35,000